Transverse Medical Inc (TMI)

TMI is developing the POINT-GUARD™ Cerebral Embolic Protection to address the devastating & costly problem of stroke during cardiovascular procedures.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Evergreen, CO, US
  • Currency USD
  • Founded March 2011
  • Employees 4
  • Incorporation Type C-corp
  • Website transversemedical.com

Company Summary

Transverse Medical Inc. is developing the POINT-GUARD™ Cerebral Embolic Protection device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement. The Point-Guard device is designed to minimize incremental procedure time and focus on ease-of-use in addition to providing maximum filter coverage.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free